Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Caspase-3 cleaved spectrin colocalizes with neurofilament-immunoreactive neurons in Alzheimer's disease.

Ayala-Grosso C, Tam J, Roy S, Xanthoudakis S, Da Costa D, Nicholson DW, Robertson GS.

Neuroscience. 2006 Aug 25;141(2):863-74. Epub 2006 Jun 5.

PMID:
16750894
3.

Caspase-cleaved amyloid precursor protein in Alzheimer's disease.

Ayala-Grosso C, Ng G, Roy S, Robertson GS.

Brain Pathol. 2002 Oct;12(4):430-41.

PMID:
12408229
5.

Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease.

Vickers JC, Riederer BM, Marugg RA, Buée-Scherrer V, Buée L, Delacourte A, Morrison JH.

Neuroscience. 1994 Sep;62(1):1-13.

PMID:
7816192
6.
7.

Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease.

Shepherd CE, Thiel E, McCann H, Halliday GM.

Neurobiol Dis. 2001 Feb;8(1):136-46.

PMID:
11162247
8.

Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease.

Rohn TT, Head E, Su JH, Anderson AJ, Bahr BA, Cotman CW, Cribbs DH.

Am J Pathol. 2001 Jan;158(1):189-98.

10.

Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain.

Rohn TT, Rissman RA, Davis MC, Kim YE, Cotman CW, Head E.

Neurobiol Dis. 2002 Nov;11(2):341-54.

PMID:
12505426
11.

Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.

Guo H, Albrecht S, Bourdeau M, Petzke T, Bergeron C, LeBlanc AC.

Am J Pathol. 2004 Aug;165(2):523-31.

12.

Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology.

Su JH, Zhao M, Anderson AJ, Srinivasan A, Cotman CW.

Brain Res. 2001 Apr 20;898(2):350-7.

PMID:
11306022
13.

Cytoplasmic cytochrome c immunolabelling in dystrophic neurites in Alzheimer's disease.

Woodhouse A, Vickers JC, Dickson TC.

Acta Neuropathol. 2006 Oct;112(4):429-37. Epub 2006 Jul 20.

PMID:
16855832
14.
16.

Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease.

Hof PR, Cox K, Young WG, Celio MR, Rogers J, Morrison JH.

J Neuropathol Exp Neurol. 1991 Jul;50(4):451-62.

PMID:
2061713
17.

The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress.

Greeve I, Hermans-Borgmeyer I, Brellinger C, Kasper D, Gomez-Isla T, Behl C, Levkau B, Nitsch RM.

J Neurosci. 2000 Oct 1;20(19):7345-52.

18.
19.

A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease.

Morrison JH, Lewis DA, Campbell MJ, Huntley GW, Benson DL, Bouras C.

Brain Res. 1987 Jul 28;416(2):331-6.

PMID:
3113670
20.

Expression of calsenilin in neurons and astrocytes in the Alzheimer's disease brain.

Jin JK, Choi JK, Wasco W, Buxbaum JD, Kozlowski PB, Carp RI, Kim YS, Choi EK.

Neuroreport. 2005 Apr 4;16(5):451-5.

PMID:
15770150
Items per page

Supplemental Content

Write to the Help Desk